246 related articles for article (PubMed ID: 25542053)
1. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053
[TBL] [Abstract][Full Text] [Related]
2. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
[TBL] [Abstract][Full Text] [Related]
3. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
[TBL] [Abstract][Full Text] [Related]
4. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Oteo J; Miró E; Pérez-Vázquez M; Navarro F
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
[TBL] [Abstract][Full Text] [Related]
5. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
6. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
Paño Pardo JR; Serrano Villar S; Ramos Ramos JC; Pintado V
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051
[TBL] [Abstract][Full Text] [Related]
7. Update on the role of ceftazidime-avibactam in the management of carbapenemase-producing Enterobacterales.
Dietl B; Martínez LM; Calbo E; Garau J
Future Microbiol; 2020 May; 15():473-484. PubMed ID: 32301348
[TBL] [Abstract][Full Text] [Related]
8. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
Bou G; Vila J; Seral C; Castillo FJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
[TBL] [Abstract][Full Text] [Related]
9. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
Asensio Á; Cantero M; Shaw E; Vergara-López S
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
Rodríguez-Baño J; Gutiérrez-Gutiérrez B; Machuca I; Pascual A
Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29444952
[TBL] [Abstract][Full Text] [Related]
11. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
Cercenado E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
[TBL] [Abstract][Full Text] [Related]
12. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms.
López-Cerero L; Almirante B
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():10-6. PubMed ID: 25542047
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic options for carbapenemase-producing Enterobacteriaceae].
Salgado P; Gilsanz F; Maseda E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():12-5. PubMed ID: 26365727
[TBL] [Abstract][Full Text] [Related]
15. Global spread of New Delhi metallo-β-lactamase 1.
Poirel L; Hombrouck-Alet C; Freneaux C; Bernabeu S; Nordmann P
Lancet Infect Dis; 2010 Dec; 10(12):832. PubMed ID: 21109172
[No Abstract] [Full Text] [Related]
16. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Martínez-Martínez L; González-López JJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
[TBL] [Abstract][Full Text] [Related]
17. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
Canoui E; Tankovic J; Bige N; Alves M; Offenstadt G
Med Mal Infect; 2014 May; 44(5):235-7. PubMed ID: 24780641
[No Abstract] [Full Text] [Related]
18. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
Savard P; Carroll KC; Wilson LE; Perl TM
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
[No Abstract] [Full Text] [Related]
19. Carbapenemase-producing Enterobacteriaceae.
Doi Y; Paterson DL
Semin Respir Crit Care Med; 2015 Feb; 36(1):74-84. PubMed ID: 25643272
[TBL] [Abstract][Full Text] [Related]
20. NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China.
Zhou G; Guo S; Luo Y; Ye L; Song Y; Sun G; Guo L; Chen Y; Han L; Yang J
Emerg Infect Dis; 2014 Feb; 20(2):340-2. PubMed ID: 24456600
[No Abstract] [Full Text] [Related]
[Next] [New Search]
